1. Masenga, Sepiso K, Mweene, Bislom C, Luwaya, Emmanuel, Chona, Makondo, Kirabo, Annet. 2023. HIV-Host Cell Interactions. In Cells, 12, . doi:10.3390/cells12101351. https://pubmed.ncbi.nlm.nih.gov/37408185/
2. Fahrioglu, Umut, Ergoren, Mahmut Cerkez, Mocan, Gamze. 2020. CCR5-Δ32 gene variant frequency in the Turkish Cypriot population. In Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 51, 1711-1717. doi:10.1007/s42770-020-00352-8. https://pubmed.ncbi.nlm.nih.gov/32734471/
3. Mehmetoglu-Gurbuz, Tugba, Yeh, Rose, Garg, Himanshu, Joshi, Anjali. 2021. Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout. In Virology journal, 18, 31. doi:10.1186/s12985-021-01501-7. https://pubmed.ncbi.nlm.nih.gov/33516234/
4. Han, S W, Sa, K H, Kim, S I, Park, J Y, Kang, Y M. 2012. CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis. In Tissue antigens, 80, 416-23. doi:10.1111/j.1399-0039.2012.01955.x. https://pubmed.ncbi.nlm.nih.gov/22924548/
5. Pandit, Aridaman, de Boer, Rob J. 2015. HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene. In Scientific reports, 5, 18088. doi:10.1038/srep18088. https://pubmed.ncbi.nlm.nih.gov/26674113/
6. McNicholl, J M, Smith, D K, Qari, S H, Hodge, T. . Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele. In Emerging infectious diseases, 3, 261-71. doi:. https://pubmed.ncbi.nlm.nih.gov/9284370/
7. Słomiński, Bartosz, Ławrynowicz, Urszula, Myśliwska, Jolanta, Skrzypkowska, Maria, Brandt, Agnieszka. 2016. CCR5-Δ32 gene polymorphism is associated with retinopathy in patients with type 1 diabetes. In Molecular and cellular endocrinology, 439, 256-260. doi:10.1016/j.mce.2016.09.009. https://pubmed.ncbi.nlm.nih.gov/27619405/
智鼠故事 
